EP 3092250 A1 20161116 - POLYNUCLEOTIDES FOR THE IN VIVO PRODUCTION OF ANTIBODIES
Title (en)
POLYNUCLEOTIDES FOR THE IN VIVO PRODUCTION OF ANTIBODIES
Title (de)
POLYNUKLEOTIDE ZUR IN-VIVO-ERZEUGUNG VON ANTIKÖRPERN
Title (fr)
POLYNUCLÉOTIDES POUR LA PRODUCTION IN VIVO D'ANTICORPS
Publication
Application
Priority
- US 201461924767 P 20140108
- US 201461924770 P 20140108
- US 201461924773 P 20140108
- US 201461924774 P 20140108
- US 201461924776 P 20140108
- US 201461924779 P 20140108
- US 201461924781 P 20140108
- US 201461924783 P 20140108
- US 201461924787 P 20140108
- US 201461924795 P 20140108
- US 201461924799 P 20140108
- US 201461924802 P 20140108
- US 201461924805 P 20140108
- US 201461924807 P 20140108
- US 201461924810 P 20140108
- US 201461924811 P 20140108
- US 201461924817 P 20140108
- US 201461924819 P 20140108
- US 201461924820 P 20140108
- US 201461924754 P 20140108
- US 201461924763 P 20140108
- US 201461924768 P 20140108
- US 201461924775 P 20140108
- US 201461924791 P 20140108
- US 201461924804 P 20140108
- US 201461924812 P 20140108
- US 201461924827 P 20140108
- US 201461924834 P 20140108
- US 201461924841 P 20140108
- US 201461924846 P 20140108
- US 201461924850 P 20140108
- US 201461993715 P 20140515
- US 2015010547 W 20150108
Abstract (en)
[origin: WO2015105926A1] The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding an antibody, variant or fragment.
IPC 8 full level
A61K 39/395 (2006.01); C07K 16/00 (2006.01); C12P 19/34 (2006.01)
CPC (source: EP)
C07K 16/18 (2013.01); C07K 16/24 (2013.01); C07K 16/28 (2013.01); C07K 16/40 (2013.01); A61K 2039/53 (2013.01); C07K 2317/14 (2013.01)
Citation (third parties)
Third party : Graf von Stosch
- WO 2013151666 A2 20131010 - MODERNA THERAPEUTICS [US]
- US 2013196377 A1 20130801 - LEE JAE-IL [KR], et al
- US 2013195867 A1 20130801 - HOERR INGMAR [DE], et al
- WO 2005075514 A2 20050818 - LONZA AG [CH], et al
- WO 2013185067 A1 20131212 - SHIRE HUMAN GENETIC THERAPIES [US]
- WO 2014152774 A1 20140925 - SHIRE HUMAN GENETIC THERAPIES [US]
- XIAOYING CHEN;ET AL.: "Fusion protein linkers: Property, design and functionality", ADVANCED DRUG DELIVERY REVIEWS,, vol. 65, no. 10, 15 October 2013 (2013-10-15), pages 1357 - 1369, XP055341428
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015105926 A1 20150716; EP 3092250 A1 20161116; EP 3092250 A4 20170524
DOCDB simple family (application)
US 2015010547 W 20150108; EP 15735068 A 20150108